ADHD
Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
CompletedNCT02900144
Official study titleModified Comprehensive Behavioral Intervention for Tics: Treating Children With Tic Disorders, Co-occurring ADHD and Psychosocial Impairment
This study has finished and is no longer accepting participants.
In BostonADHDBehavioural studyAges 10–17
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT01692548
Official study titleEffect of Neurofeedback Intervention on the Development of ADHD in Children at Risk: a Comparative Study.
This study has finished and is no longer accepting participants.
In Porto AlegreADHDInterventional studyAges 6–10
- Countries
- Brazil
- Sponsor
- Hospital de Clinicas de Porto Alegre
TerminatedNCT03279952
This study ended early.
In HersheyADHDMedication studyAges 5–12
- Countries
- United States
- Sponsor
- Milton S. Hershey Medical Center
CompletedNCT00573248
Official study titleNicotine and Behavioral Regulation in Adult ADHD
This study has finished and is no longer accepting participants.
In IrvineADHDMedication studyAges 18–45
- Countries
- United States
- Sponsor
- University of California, Irvine
CompletedNCT00914862
Official study titleA Comparative Single Dose Pharmacokinetic and Safety Study of 4 mg or 8 mg Ramelteon in Adolescents With Insomnia Characterized by Difficulty With Sleep Onset, Children With Insomnia Associated With ADHD, and Healthy Adults.
This study has finished and is no longer accepting participants.
Multiple locations, including Overland ParkADHDMedication studyAges 6–50
- Countries
- United States
- Sponsor
- Takeda
CompletedNCT02023606
Official study titleAn Open-Label, Single-Dose, Mass-Balance Study to Assess the Absorption, Metabolism, and Excretion (AME) of [14C] Labeled SPN-810M in Healthy Adult Male Volunteers
This study has finished and is no longer accepting participants.
In RuddingtonADHDMedication studyAges 30–55
- Countries
- United Kingdom
- Sponsor
- Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
CompletedNCT04232644
Official study titleA Pilot, Randomized, Double-Blind, Active-Controlled, 2-Treatment, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Abuse Liability of Dextroamphetamine Sulfate From an Abuse-Deterrent Immediate-Release Formulation (ADAIR)
This study has finished and is no longer accepting participants.
In TorontoADHDMedication studyAges 18–55
- Countries
- Canada
- Sponsor
- Vallon Pharmaceuticals, Inc.
CompletedNCT05862727
Official study titlePreschool Attention and Sleep Support (PASS): A Telehealth Intervention for Children at Risk for ADHD
This study has finished and is no longer accepting participants.
In DurhamADHDBehavioural studyAges 3–5
- Countries
- United States
- Sponsor
- Duke University
CompletedNCT00622427
Official study titleRamelteon for Treatment of Adult Patients With ADHD-Related Insomnia
This study has finished and is no longer accepting participants.
In BirminghamADHDMedication studyAges 19–65
- Countries
- United States
- Sponsor
- University of Alabama at Birmingham
CompletedNCT06560359
Official study titleNeurobehavioral Effects of Increased Fruit and Vegetable Intake on Cognition, Mood, and Attention in 7-11-Year-Old Children From Shanghai: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In ShanghaiADHDPlacebo comparisonAges 7–11
- Countries
- China
- Sponsor
- Fudan University
TerminatedNCT00266955
Official study titleA Retrospective Study of Children With ADHD and Cardiac Symptoms
This study ended early.
In AtlantaADHDObservational studyUp to age 18
- Countries
- United States
- Sponsor
- Children's Healthcare of Atlanta
CompletedNCT00297739
This study has finished and is no longer accepting participants.
In Coral GablesADHDMedication studyAges 7–12
- Countries
- United States
- Sponsor
- Armenteros, Jorge L., M.D., P.A.